Gyre Therapeutics (GYRE) Shareholder's Equity (2010 - 2026)
Gyre Therapeutics (GYRE) Shareholder's Equity (2010 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Shareholder's Equity (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
7.14 Bn |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
795.79 Mn |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
595,226.00 |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
1.00 Bn |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
14.38 Mn |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
19.36 Bn |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
502.95 Mn |
| 10 |
Gyre Therapeutics |
548.82 Mn |
534.69 Mn |
8.38 Mn |
136.99 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
136.99 Mn |
| Dec 31, 2025 |
106.03 Mn |
| Sep 30, 2025 |
101.92 Mn |
| Jun 30, 2025 |
129.44 Mn |
| Mar 31, 2025 |
104.30 Mn |
| Dec 31, 2024 |
98.40 Mn |
| Sep 30, 2024 |
98.47 Mn |
| Jun 30, 2024 |
93.35 Mn |
| Mar 31, 2024 |
88.77 Mn |
| Dec 31, 2023 |
13.95 Mn |
| Sep 30, 2023 |
85.32 Mn |
| Jun 30, 2023 |
77.47 Mn |
| Mar 31, 2023 |
77.33 Mn |
| Dec 31, 2022 |
72.22 Mn |
| Sep 30, 2022 |
29.38 Mn |
| Jun 30, 2022 |
79.06 Mn |
| Mar 31, 2022 |
27.08 Mn |
| Dec 31, 2021 |
59.47 Mn |
| Sep 30, 2021 |
60.74 Mn |
| Jun 30, 2021 |
85.16 Mn |
